The focus of this work has been to understand the molecular details that control the interaction of MHC molecules with NK receptors, T cell receptors, and with coreceptors such as CD8. These studies are dependent upon structural, functional, and biophysical analysis of the interaction of the molecules in question, and attempts are made to correlate binding properties with function and structure. Progress in the past year has been particularly fruitful with respect to our understanding of MHC-I-like molecules encoded by cytomegaloviruses. In particular, we have cloned, expressed, purified, crystallized, and determined the three-dimensional structure to 1.9 A resolution of the first example of an MHC-I-like molecule encoded by the murine cytomegalovirus, m144. This reveals a molecule that lacks bound peptide, maintains the major MHC-I fold, but has unique structural features that contribute to thermal stability. Mutagenesis experiments confirm the importance of a unique disulfie bond of this molecule. In addition, we have examined the cellular expression of three additional cytomegalovirus MHC-Iv immunoevasins, M37, m151, and m153. Each of these has unique cell biological features. Studies are underway to explore the biochemistry, cellular immunology, and structure of each of these unique, virus-encoded receptors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000622-14
Application #
7192924
Study Section
(LI)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2005
Total Cost
Indirect Cost
Name
Niaid Extramural Activities
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Margulies, David H (2009) Antigen-processing and presentation pathways select antigenic HIV peptides in the fight against viral evolution. Nat Immunol 10:566-8
Dzutsev, Amiran K; Belyakov, Igor M; Isakov, Dmitry V et al. (2008) Estimation of low frequency antigen-presenting cells with a novel RELISPOT assay. J Immunol Methods 333:71-8
Belyakov, Igor M; Kozlowski, Steven; Mage, Michael et al. (2007) Role of alpha3 domain of class I MHC molecules in the activation of high- and low-avidity CD8+ CTLs. Int Immunol 19:1413-20
Dzutsev, Amiran H; Belyakov, Igor M; Isakov, Dmitry V et al. (2007) Avidity of CD8 T cells sharpens immunodominance. Int Immunol 19:497-507
Mans, Janet; Natarajan, Kannan; Balbo, Andrea et al. (2007) Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J Biol Chem 282:35247-58
Natarajan, Kannan; Hicks, Ashleigh; Mans, Janet et al. (2006) Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358:157-71
Hu, Jin-Shan; Plaksin, Daniel; Margulies, David H (2005) Backbone and side chain resonance assignmentsof a TRAV14-3 mouse T cell receptor domain. J Biomol NMR 31:271-2
Kuribayashi, Hideki; Wakabayashi, Ayako; Shimizu, Masumi et al. (2004) Resistance to viral infection by intraepithelial lymphocytes in HIV-1 P18-I10-specific T-cell receptor transgenic mice. Biochem Biophys Res Commun 316:356-63
Margulies, David H (2003) Molecular interactions: stiff or floppy (or somewhere in between?). Immunity 19:772-4
Dam, Julie; Guan, Rongjin; Natarajan, Kannan et al. (2003) Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2K(b). Nat Immunol 4:1213-22

Showing the most recent 10 out of 31 publications